SLC16A7 and Cerebral ischemia: Genetic or pharmacological inhibition of the monocarboxylate transporters (MCT2), particularly the MCT2, may aid in understanding whether both lactate and DBHB mediate exercise's neuroprotective effects after cerebral ischemia.